Nektar Therapeutics
NKTR
#4621
Rank
ยฃ1.78 B
Marketcap
ยฃ52.71
Share price
6.76%
Change (1 day)
180.44%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : ยฃ0.14 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are ยฃ0.14 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31ยฃ0.14 B-26.95%
2024-12-31ยฃ0.19 B-7.58%
2023-12-31ยฃ0.20 B-26.27%
2022-12-31ยฃ0.28 B-12.32%
2021-12-31ยฃ0.32 B-4.23%
2020-12-31ยฃ0.33 B-22.38%
2019-12-31ยฃ0.43 B27.99%
2018-12-31ยฃ0.34 B9.39%
2017-12-31ยฃ0.31 B-20.04%
2016-12-31ยฃ0.38 B17.3%
2015-12-31ยฃ0.33 B27.59%
2014-12-31ยฃ0.26 B-18.12%
2013-12-31ยฃ0.31 B14%
2012-12-31ยฃ0.27 B6.05%
2011-12-31ยฃ0.26 B-5.71%
2010-12-31ยฃ0.27 B-4.61%
2009-12-31ยฃ0.29 B15.7%
2008-12-31ยฃ0.25 B-1.69%
2007-12-31ยฃ0.25 B-6.95%
2006-12-31ยฃ0.27 B-10.41%
2005-12-31ยฃ0.30 B113.26%
2004-12-31ยฃ0.14 B-42.85%
2003-12-31ยฃ0.25 B1.45%
2002-12-31ยฃ0.24 B-8.9%
2001-12-31ยฃ0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
ยฃ90.39 B 63,896.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ88.50 B 62,562.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ62.90 B 44,439.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ10.44 B 7,293.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ62.48 B 44,140.46%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ50.31 B 35,521.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
ยฃ32.68 M-76.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
ยฃ1.89 B 1,240.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland